Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 24, 2025, titled "Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to Innovative Immuno-Oncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma".